AceclofenacThird Party Manufacturing in India

Aceclofenac is a non-steroidal anti-inflammatory drug belonging to the phenylacetic acid class, structurally related to diclofenac, that exerts its analgesic, anti-inflammatory, and antipyretic effects primarily through inhibition of cyclooxygenase enzymes. Aceclofenac demonstrates preferential inhibition of COX-2 over COX-1, with a COX-2 selectivity ratio that is higher than diclofenac and comparable to meloxicam, providing effective anti-inflammatory activity with a reduced potential for gastrointestinal adverse effects compared to non-selective NSAIDs. By blocking cyclooxygenase activity, aceclofenac prevents the conversion of arachidonic acid to prostaglandin H2, the precursor of prostaglandins, prostacyclin, and thromboxanes that mediate pain, inflammation, and fever. Aceclofenac also inhibits the production of pro-inflammatory cytokines including interleukin-1 beta and tumour necrosis factor-alpha, and reduces the expression of adhesion molecules on endothelial cells, further contributing to its anti-inflammatory effects. Additionally, aceclofenac stimulates the synthesis of glycosaminoglycans in articular cartilage, which may provide a chondroprotective effect that distinguishes it from some other NSAIDs in the management of osteoarthritis. The soft gelatin capsule formulation incorporates solubilising agents that enhance the dissolution rate and oral absorption of this poorly water-soluble drug, leading to faster onset of analgesia compared to conventional tablet formulations.

Therapeutic Uses

Aceclofenac is indicated for the symptomatic treatment of pain and inflammation:

• Osteoarthritis: Provides effective relief of joint pain, stiffness, and functional limitation in osteoarthritis of the knee and hip, with potential chondroprotective benefits through stimulation of glycosaminoglycan synthesis in cartilage.
• Rheumatoid Arthritis: Reduces joint swelling, morning stiffness, and pain in patients with active rheumatoid arthritis, improving physical function and quality of life.
• Ankylosing Spondylitis: Alleviates inflammatory back pain and spinal stiffness in patients with this chronic inflammatory spinal condition.
• Acute Musculoskeletal Pain: Effective for soft tissue injuries, sprains, strains, and tendinitis where rapid anti-inflammatory and analgesic effects are required.
• Dental Pain: Provides effective pain relief following dental surgical procedures, with the softgel formulation offering particularly rapid absorption for acute post-procedural pain.
• Dysmenorrhea: Reduces prostaglandin-mediated uterine cramping and pain associated with primary dysmenorrhea.

Why Manufacturers Choose Aceclofenac

Aceclofenac is one of the most prescribed NSAIDs in the Indian pharmaceutical market, favoured by physicians for its favourable gastrointestinal safety profile compared to diclofenac and its balanced efficacy across inflammatory and pain conditions. The soft gelatin capsule formulation represents a value-added dosage form that commands premium pricing compared to standard tablets while offering faster absorption and improved patient acceptability, particularly among elderly patients who may have difficulty swallowing tablets. Indian WHO-GMP certified manufacturers produce aceclofenac softgel capsules for the domestic PCD franchise market and for export to regulated markets. The well-established API supply chain, proven formulation technology for soft gelatin encapsulation, and consistent year-round demand from orthopaedic and rheumatology practices make aceclofenac softgel capsules a profitable and sustainable product for third party manufacturing operations in India.